1. 527 Tumor organoid and immune cell co-culture system potentiates immuno-oncology drug development. (10th December 2020) Authors: Zhang, Hongjuan; Zhou, Jun; Zhu, Shuang; Zheng, Jia; Shang, Limei; Li, Chunmei; Yan, Xuefei; Zhang, Rui; Zang, Mingfa; An, Annie Xiaoyu; Xu, Xiaoxi; Wang, Shuzong; Li, Henry; Huang, Yujun Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A322 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 12 Development of an in vitro assay to assess bispecific T cell engager using T cells from CD3e humanized mice. (9th November 2020) Authors: Zhou, Jun; Zhu, Shuang; Zhang, Hongjuan; Zheng, Lei; Zang, Mingfa; An, Annie Xiaoyu; Wang, Shuzong; Ouyang, Davy Xuesong; Li, Henry; Huang, Yujun Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 12 Development of an in vitro assay to assess bispecific T cell engager using T cells from CD3e humanized mice. (9th November 2020) Authors: Zhou, Jun; Zhu, Shuang; Zhang, Hongjuan; Zheng, Lei; Zang, Mingfa; An, Annie Xiaoyu; Wang, Shuzong; Ouyang, Davy Xuesong; Li, Henry; Huang, Yujun Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 527 Tumor organoid and immune cell co-culture system potentiates immuno-oncology drug development. (9th November 2020) Authors: Zhang, Hongjuan; Zhou, Jun; Zhu, Shuang; Zheng, Jia; Shang, Limei; Li, Chunmei; Yan, Xuefei; Zhang, Rui; Zang, Mingfa; An, Annie Xiaoyu; Xu, Xiaoxi; Wang, Shuzong; Li, Henry; Huang, Yujun Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A563 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 237 In vitro potency assays for immune checkpoint blockade using human primary cells, murine huGEMM immune cells and patient-derived tumor organoids. (9th November 2020) Authors: Yan, Xuefei; Zhang, Hongjuan; Zhou, Jun; Zheng, Jia; Zhu, Shuang; Zhang, Rui; Zang, Mingfa; An, Annie Xiaoyu; Xu, Xiaoxi; Wang, Shuzong; Xu, Kevin Qijin; Ouang, Davy Xuesong; Li, Henry; Huang, Yujun Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 237 In vitro potency assays for immune checkpoint blockade using human primary cells, murine huGEMM immune cells and patient-derived tumor organoids. (9th November 2020) Authors: Yan, Xuefei; Zhang, Hongjuan; Zhou, Jun; Zheng, Jia; Zhu, Shuang; Zhang, Rui; Zang, Mingfa; An, Annie Xiaoyu; Xu, Xiaoxi; Wang, Shuzong; Xu, Kevin Qijin; Ouang, Davy Xuesong; Li, Henry; Huang, Yujun Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Immunomodulator FTY720 improves glucose homeostasis and diabetic complications by rejuvenation of β‐cell function in nonhuman primate model of diabetes. (2nd February 2022) Authors: Wang, Yixin (Jim); Wang, Xiaoli; An, Annie; Zang, Mingfa; Xu, Ling; Gong, Kefeng; Song, Weihua; Li, Qing; Lu, Xiaojun; Xiao, Yong‐Fu; Yu, Guoliang; Ma, Zhongmin A. Journal: Fundamental & clinical pharmacology Issue: Volume 36:Number 4(2022) Page Start: 699 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗